Cambrex Invests $120 Million to Enhance API Production and US Drug Supply Stability Cambrex announces a significant $120 million investment to strengthen its US API manufacturing capacity, boosting the pharmaceutical supply chain's resilience and meeting rising demand.

Cambrex Invests $120 Million to Enhance API Production and US Drug Supply Stability #United_States #Cambrex #East_Rutherford #API_Production #US_Drug_Supply

Clarivate Report Reveals Strategic Pathways for Pharmaceutical Growth in Latin America Clarivate's latest white paper sheds light on growth opportunities within Latin America's pharmaceutical sector, focusing on innovation and collaboration.

Clarivate Report Reveals Strategic Pathways for Pharmaceutical Growth in Latin America #United_States #London #Latin_America #Clarivate #API_Production